Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

newswire.ca - Innocan Pharma Announces First Tranche Closing of Private Placement of Units
Innocan Pharma Announces First Tranche Closing of Private Placement of Units
CNW

HERZLIYA, Israel and CALGARY, Alberta, Sept. 23, 2026 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the 'Company' or 'Innocan') is pleased to announce that, further to its press release of September 9, 2026, it has…

seekingalpha.com - SA Transcripts - BridgeBio Pharma, Inc. (BBIO) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum Transcript
BridgeBio Pharma, Inc. (BBIO) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum Transcript
Seeking Alpha

BridgeBio Pharma, Inc. (BBIO) Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum September 23, 2026 9:40 AM EDT Thomas Trimarchi - CFO & President Julie Everett - Chief Operating Officer of Skeletal Dysplasias…

fool.com - Katie Brockman - XLV vs. PJP: How Broad Healthcare Diversification Stacks Up to Pharma Stocks
XLV vs. PJP: How Broad Healthcare Diversification Stacks Up to Pharma Stocks
The Motley Fool

Investors seeking healthcare exposure must decide between the broad diversification of the healthcare sector and a targeted bet on pharmaceutical manufacturers. The State Street Health Care Select Sector SPDR ETF (XLV -0.64%) provides broad…

thehindubusinessline.com - Pharma revenue growth to accelerate to 11-13% this fiscal: Crisil
Pharma revenue growth to accelerate to 11-13% this fiscal: Crisil
BusinessLine

Indian pharma revenue growth is expected to accelerate to 11-13 per cent this fiscal from 8 per cent last year, driven by a 14-16 per cent rise in exports as drugmakers expand beyond the US into Europe, Asia, Africa and Latin America, ratings…

marketbeat.com - Helus Pharma Eyes Q4 Phase III Data for HLP-003 in Major Depression
Helus Pharma Eyes Q4 Phase III Data for HLP-003 in Major Depression
MarketBeat

Magic Mushrooms, Hard Cash: Compass Pathways' Trial Win, Fast Raise Helus Pharma, formerly known as Cybin NASDAQ: HELP, outlined its late-stage development plans for HLP-003 in adjunctive major depressive disorder (MDD) and discussed its broader…

marketbeat.com - Avalyn Pharma (NASDAQ:AVLN) Stock Price Down 9.2% - Here's Why
Avalyn Pharma (NASDAQ:AVLN) Stock Price Down 9.2% - Here's Why
MarketBeat

Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report)'s stock price dropped 9.2% during mid-day trading on Wednesday. The stock traded as low as $29.14 and last traded at $29.47. 130,560 shares traded hands during mid-day trading, a decline of 58%…

marketbeat.com - Nuvectis Pharma (NASDAQ:NVCT) Shares Down 7.5% - Should You Sell?
Nuvectis Pharma (NASDAQ:NVCT) Shares Down 7.5% - Should You Sell?
MarketBeat

Nuvectis Pharma, Inc. (NASDAQ:NVCT - Get Free Report) fell 7.5% during mid-day trading on Wednesday. The stock traded as low as $21.53 and last traded at $21.2710. 28,119 shares were traded during mid-day trading, a decline of 84% from the average…

globenewswire.com - Roquette Frères - Strategic Transformation Supports Roquette's H1 2026 Performance
Strategic Transformation Supports Roquette's H1 2026 Performance
GlobeNewswire

Strategic Transformation Supports Roquette's H1 2026 Performance +9% turnover growth to €2,586 million and +18% Current EBITDA increase to €337 million. Performance was supported by favorable volume and mix effects, the continued…

seekingalpha.com - SA Transcripts - Moderna, Inc. (MRNA) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum Transcript
Moderna, Inc. (MRNA) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum Transcript
Seeking Alpha

Moderna, Inc. (MRNA) Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum September 23, 2026 8:50 AM EDT Stéphane Bancel - CEO & Director David Berman - Chief Development Officer Courtney Breen - Bernstein…

marketwatch.com - Eli Lilly, InnoCare Sign Deal That Could Top $3 Billion
Eli Lilly, InnoCare Sign Deal That Could Top $3 Billion
MarketWatch

InnoCare, a specialist in cancer and autoimmune diseases, will use its proprietary drug-discovery platform to develop new medicines with the U.S. pharma giant. Under the terms of the Thursday agreement, InnoCare will be eligible for up to $100…

rediff.com - Nandita Malik - Sensex Plunges 600+ Points: Crude Oil Above $100, Global Cues Weigh on Indian Markets
Sensex Plunges 600+ Points: Crude Oil Above $100, Global Cues Weigh on Indian Markets
Rediff.com

Indian benchmark indices, Sensex and Nifty, witnessed a sharp decline in early trade as crude oil prices surged past $100 per barrel, coupled with weak global market trends, impacting investor sentiment. The BSE Sensex plummeted 632.68 points, and…

seekingalpha.com - SA Transcripts - Teva Pharmaceutical Industries Limited (TEVA) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Teva Pharmaceutical Industries Limited (TEVA) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Seeking Alpha

Teva Pharmaceutical Industries Limited (TEVA) Bank of America Global Healthcare Conference 2026 September 23, 2026 5:55 AM EDT Richard Francis - President, CEO & Director Jason Gerberry - BofA Securities, Research Division BofA Securities, Research…

globenewswire.com - Boehringer Ingelheim Limited - Boehringer Ingelheim and WHO Foundation launch global collaboration to close the gap in obesity and metabolic health
Boehringer Ingelheim and WHO Foundation launch global collaboration to close the gap in obesity and metabolic health
GlobeNewswire

Supporting obesity and metabolic health with a USD 5 million contribution from Boehringer Ingelheim over three years Collaboration will strengthen integrated care for obesity and related cardiovascular, kidney, liver and metabolic diseases to…

rediff.com - Rediff News - NSE enters 'top 10 most valued firms' club; shares jump 5%
NSE enters 'top 10 most valued firms' club; shares jump 5%
Rediff.com

Shares of National Stock Exchange of India Ltd (NSE) jumped over 5 per cent during intraday trade on Thursday after a muted debut and entered the elite club of top-10 most valued firms by market valuation. The exchange started trading at Rs 1,800…

seekingalpha.com - High Alpha Professor - BW LPG: A 10-12 Month Buy Before New Supply Catches Up (NYSE:BWLP)
BW LPG: A 10-12 Month Buy Before New Supply Catches Up (NYSE:BWLP)
Seeking Alpha

BW LPG Limited is earning record VLGC rates, with Q3 mostly fixed at $88,000/day versus a $24,900/day breakeven. I see at least 10–12 more months of elevated profits, underpinned by persistent trade route disruptions and slow Middle East…

Receive a Daily briefing on Pharma Industry News

Get Started